Peter Caravan, PhD
Director, Institute for Innovation in Imaging
Massachusetts General Hospital
Associate Professor of Radiology
Harvard Medical School
Wednesday, April 3rd | 4:00 pm
Coffee and dessert will be served at 3:45 pm
Biomedical Imaging Across the Periodic Table
Our lab focuses on the development and clinical translation of molecular imaging probes to detect and quantify disease, to improve prognosis, and to monitor therapy response. For imaging, we utilize magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), and computed tomography (CT) alone or in combination. Our approach to addressing unmet medical needs has been top down and agnostic with respect to the modality and imaging reporter. As a result, we’ve utilized diverse chemistries employing a range of elements to create signal or contrast. Here, I will give examples of this work with applications in cardiovascular disease, interstitial lung disease, nonalcoholic steatohepatitis, and pancreatitis.
Peter Caravan is the Director of the Institute for Innovation in Imaging (i3) at Massachusetts General Hospital and Associate Professor of Radiology at Harvard Medical School. He leads a multidisciplinary and translational molecular imaging lab focused on the invention of novel molecular probes and their broad applications in cardiovascular, pulmonary, renal, and hepatic diseases as well as in cancers. His research spans novel chemistry technologies to advanced MRI and PET imaging in animal models to applications in patient populations. Dr. Caravan received a PhD in Inorganic Chemistry from the University of British Columbia. Following post-doctoral work at the EPFL (Switzerland) he worked in industry developing targeted MR probes. He joined the faculty of Harvard Medical School in 2007 and has been a continuously funded NIH researcher.
Hosted by NIGMS fellow Megan Kaster. This is a required activity for CLP Trainees. Supported by the Chemistry of Life Processes Predoctoral Training Program NIH/ NIGMS 5T32GM105538-06